Nadolol

In the US, Nadolol (nadolol systemic) is a member of the drug class non-cardioselective beta blockers and is used to treat Angina, Anxiety, Benign Essential Tremor, Esophageal Variceal Hemorrhage Prophylaxis, Glaucoma, High Blood Pressure, Lithium Tremor, Migraine Prevention, Mitral Valve Prolapse, Parkinsonian Tremor and Supraventricular Tachycardia.

US matches:

• Nadolol


• Nadolol and bendroflumethiazide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C07AA12

CAS registry number (Chemical Abstracts Service)

0042200-33-9

Chemical Formula

C17-H27-N-O4

Molecular Weight

309

Therapeutic Category

ß-Adrenergic blocking agent

Chemical Names

1-(tert-Butylamino)-3-[(5,6,7,8-tetrahydro-cis-6,7-dihydroxy-1-naphthyl)oxy]-2-propanol (WHO)

2,3-Naphthalenediol, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,2,3,4-tetrahydro-

Foreign Names

• Nadololum (Latin)
• Nadolol (German)
• Nadolol (French)
• Nadolol (Spanish)

Generic Names

• Nadolol (OS: JAN, DCF, USAN, BAN)
• Nadololo (OS: DCIT)
• SQ 11725 (IS: Squibb)
• Nadolol (PH: BP 2010, JP XIV, USP 32, Ph. Eur. 6)
• Nadololum (PH: Ph. Eur. 6)

Brand Names

• Anabet
  Bristol-Myers Squibb, Portugal



• Apo-Nadol
  Apotex, Canada



• Apo-Nadolol
  Apotex, New Zealand



• Begen
  Tatsumi Kagaku, Japan



• Corgard
  Bristol-Myers Squibb, Argentina; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Bahrain; Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb, Chile; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Kenya; Bristol-Myers Squibb, Luxembourg; Bristol-Myers Squibb, Peru; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, Tanzania; Bristol-Myers Squibb, Uganda; Bristol-Myers Squibb, Venezuela; King, United States; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom



• Corzide (Nadolol and Bendroflumethiazide)
  King, United States



• Nadic
  Dainippon Sumitomo, Japan



• Nadolol and Bendroflumethazide (Nadolol and Bendroflumethazide)
  Impax, United States; Mylan, United States



• Nadolol
  Mylan, United States; Remedica, Cyprus; Sandoz, United States; Teva USA, United States; UDL, United States



• Naodoriru
  Tsuruhara Seiyaku, Japan



• Solgol
  Sanofi-Aventis S.A., Spain

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.